Androgen receptors in untreated and treated prostatic intraepithelial neoplasia

Eur Urol. 1996;30(2):265-8. doi: 10.1159/000474179.

Abstract

Objectives: The effect of androgen deprivation therapy on the expression of androgen receptors (AR) and the proliferation-associated MIB-1 antigen in prostatic intraepithelial neoplasia (PIN) was investigated.

Methods: Immunohistochemistry was performed on tissue sections of prostatectomy specimens of patients with prostate cancer who either were not treated prior to surgery or received androgen blockade therapy for 3 months. Immunohistochemistry on slides, selected for the presence of PIN was performed with an AR-specific monoclonal antibody and MIB-1 using a microwave antigen-retrieval method.

Results: AR expression was present in a majority of cells in PIN of both untreated and treated prostatectomy specimens. In addition, a proportion of normal prostatic glandular cells retained AR expression. The basal cells in both untreated and treated PIN did not express AR. MIB-1-positive cells were identified in PIN of untreated and treated cases.

Conclusions: PIN lesions that persist after 3 months of androgen deprivation therapy continue to express AR and may therefore retain the potential to expand after cessation of this therapy.

MeSH terms

  • Androgen Antagonists / administration & dosage
  • Androgen Antagonists / therapeutic use*
  • Antibodies, Monoclonal / immunology
  • Antibody Specificity
  • Antigen-Antibody Complex
  • Humans
  • Immunohistochemistry
  • Ki-67 Antigen / analysis
  • Male
  • Paraffin Embedding
  • Prostate-Specific Antigen / blood
  • Prostatectomy
  • Prostatic Intraepithelial Neoplasia / drug therapy*
  • Prostatic Intraepithelial Neoplasia / radiotherapy
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / radiotherapy
  • Receptors, Androgen / biosynthesis*

Substances

  • Androgen Antagonists
  • Antibodies, Monoclonal
  • Antigen-Antibody Complex
  • Ki-67 Antigen
  • Receptors, Androgen
  • Prostate-Specific Antigen